Discover diagnostic and research solutions trusted by hospitals, biotech firms, and clinical labs worldwide.
Years Experienced
Projects
Global Partners
At Auralys Therapeutics, we develop and supply advanced solutions for diagnostics, clinical trials, and pharmaceutical research. Our expertise ensures accuracy, consistency, and compliance at every stage.
Accelerating drug candidate identification through deep learning and big data analytics.
Combining AI and experimental biology to uncover and confirm promising disease targets.
Designing optimized molecules using advanced modeling and structure predictions.
Rapidly testing and refining compounds with scalable in vitro and in vivo systems.
Conducting in-depth pharmacological and safety studies before entering clinical trials.
Executing rigorous human trials to evaluate safety, efficacy, and therapeutic potential.
Developing highly targeted therapies tailored to specific disease pathways.
Ensuring successful market access through strategic planning and global compliance.
Auralys Therapeutics leads pioneering research that fuses advanced biology with AI-driven discovery. Our lab teams work on transforming complex disease mechanisms into targeted therapies with real-world impact.
We collaborate with leaders in science, technology, and clinical research. Here’s what some of them have to say about working with Auralys Therapeutics.
At Auralys Therapeutics, we believe true innovation happens when science, technology, and passion come together. Our team experiments, learns, and grows together every month to push the boundaries of what’s possible in modern medicine.
To transform lives through AI-driven precision therapeutics and breakthrough drug discovery.
We combine science, strategy, and innovation to accelerate the development of targeted therapies.
Driven by purpose. Powered by science. Inspired by impact.
Our dedicated experts bring together decades of scientific research, biotech strategy, and clinical innovation to pioneer tomorrow’s therapies.
Be a part of our mission to accelerate breakthroughs in drug discovery and biotechnology through cutting-edge research and collaboration.
Auralys Therapeutics is pleased to announce the appointment of Dr. Laila Monroe, M.D., as Chief
Auralys Therapeutics presented encouraging preclinical data for its lead candidate, AUR-101, at the prestigious BioTechX
Auralys Therapeutics, a next-generation biotech company pioneering AI-powered drug discovery, has successfully raised $45 million
Our mission is to accelerate breakthrough therapies that improve patient outcomes, focusing on diseases with high unmet medical needs. With a world-class team of scientists, drug developers, and industry leaders, Auralys Therapeutics is committed to delivering transformative medicines to the world.
Get the latest updates on scientific breakthroughs, pipeline progress, and company news from Auralys Therapeutics — directly to your inbox.
